PrEP Considerations for Transgender and Nonbinary Individuals

In this episode, Jill Blumenthal, MD, MAS, discusses HIV pre-exposure prophylaxis (PrEP) considerations for transgender and nonbinary individuals, including:

  • Providing gender-affirming care
  • Integrating PrEP and gender care
  • Taking a sexual history and addressing sexual health
  • PrEP efficacy and options for transgender individuals, including FTC/TDF, FTC/TAF, and long-acting CAB
  • The importance of reassuring transgender individuals that data suggest there are no drug–drug interactions between gender-affirming hormone therapy and any of the PrEP options 

Jill Blumenthal, MD, MAS (she/hers)Associate Professor of MedicineInfectious Diseases and Global Public HealthUniversity of California, San DiegoSan Diego, California 

See the full program at: https://bit.ly/3WhbBvZ


Отзывы


Podcastly – the best platform for podcasters and podcast lovers. More than 10 millions of audio content that available on Android/iOS/Web/Desktop and Telegram.